InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the full record of transactions filed by ORTH ANDREW C.. Director active across 1 company, notably Krystal Biotech, Inc.. Aggregated, 1 disclosures have been published. Activity tracked since 9 June 2023. The latest transaction was disclosed on 9 June 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration